Growing Cosmetic Scar Treatment Spurs Growth in the North America Scar Treatment Market
![]() |
North America Scar Treatment Market |
Market
Overview:
The North
America scar treatment market comprises products used for healing, improving
appearance, and reducing appearance of scars. Scars are physical marks left on
the skin after wound healing. Common causes of scarring include injuries,
burns, acne, and surgery. Various scar treatment products include creams, gels,
sheets, laser therapy devices, injections, and others. These products aid
faster healing, improve scar appearance, reduce redness and darkness, increase
elasticity and hydration of scar tissue. Growth in cosmetic consciousness and
personal care spending drives demand for scar treatment in the region.
Market key trends:
One of the key trends in the North America scar treatment market is
increasing preference for minimally invasive procedures. Laser therapy and
injectable treatments offer minimally invasive options for scar treatment and
removal. Laser therapy utilizes specific wavelengths of light to break down
scar tissue formation. It helps fade scars, improve texture and color of
scarred skin. Injectable treatments such as corticosteroids and hyaluronic acid
reduce inflammation and improve hydration of scar tissue respectively. They
provide deep treatment within the dermis for improved efficacy over topical
products. This drives the growing adoption of minimally invasive scar treatment
procedures.
Porter's Analysis
Threat of new entrants: The North
America Scar Treatment Market Demand is expected to experience moderate
threat of new entrants due to the high costs involved in research and
development of treatment procedures and technologies.
Bargaining power of buyers: Individual consumers have moderate bargaining power
in the market as there are many alternatives available for scar treatment
procedures. However, healthcare providers and institutions have high bargaining
power as they can negotiate pricing with large medical device companies.
Bargaining power of suppliers: The suppliers of technologies and treatment
devices have moderate-to-high bargaining power due to the proprietary nature of
treatment technologies and level of innovation required. This enables suppliers
to influence pricing.
Threat of new substitutes: There is a high threat of new substitutes and
alternative procedures emerging in the market. Companies invest heavily in
R&D to develop novel technologies with fewer side effects.
Competitive rivalry: The market experiences high competitive rivalry owing to
the presence of many international and regional players offering similar scar
treatment products and technologies.
Key Takeaways
The North America scar treatment market is expected to witness high growth,
exhibiting CAGR of 4.3% over the
forecast period, due to increasing adoption of minimally invasive procedures.
The U.S. currently dominates the market due to better healthcare infrastructure
and rising medical tourism. Growing awareness about alternative aesthetic
procedures and non-invasive nature of treatments also contribute to the
regional market growth. The availability of advanced scar treatment
technologies and procedures further supports market expansion in the country.
Key players operating in the North America scar treatment market are ScarAway,
Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith & Nephew Inc, Merz
Therapeutics, Enaltus LLC, Oculus Innovative Sciences, Inc, CCA Industries,
Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma
Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson Surface Treatment,
Inc., Quantum Health, AVITA Medical, Revitol Corp, Scarguard labs, Lumenis Be
Ltd, Cynosure, GC Aesthetics, Sientra, Inc, SkinCeuticals, Cimeosil.com,
Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd. These manufacturers
are focusing on new product launches and inorganic growth strategies to gain
market share.
Read More:
https://www.dailyprbulletin.com/north-america-scar-treatment-market-value-analysis/ |
Comments
Post a Comment